This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 11Schizophrenia
- 3Psychosis
- 2Diagnosis
- 2Functional magnetic resonance imaging
- 1Adhd
- 1Alcoholism--Psychological aspects
- 2Paylor, John W
- 1Al-Ghamdi,Mohammad S
- 1Bresee, Lauren
- 1Lakusta, Bonnie J
- 1MacKay, Mary-Anne B
- 1Mickelow, Garry Stephen
-
Spring 2012
The association between stimulant drug use and the presence of a psychotic disorder raises questions about causation. Substance-induced psychosis may differ etiologically from schizophrenia despite similar phenotypic presentation. It is possible that stimulant drug users who develop symptoms of...
-
Spring 2017
Cannabis use is a known risk factor for the development of psychotic disorders. Clinical and preclinical genetic studies provide growing evidence that genes related to dopamine signalling and neuroprotection, like COMT, are implicated in the cannabis-psychosis association. Considering the burden...
-
Fall 2012
Functional Magnetic Resonance Imaging (fMRI) measures the dynamic activity of each voxel of a brain. This dissertation addresses the challenge of learning a diagnostic classifier that uses a subject’s fMRI data to distinguish subjects with neuropsychiatric disorders from healthy controls. fMRI...
-
Fall 2020
While it is very difficult to diagnose/prognosis psychiatric disorders reliably, especially in early course, such early diagnosis/prognosis is critical for producing an effective treatment. This necessity has motivated many researchers to apply machine learning approaches to high-dimensional...
-
Mental health and chronic medical conditions: schizophrenia, its treatment, risk of metabolic complications, and health care utilization
DownloadFall 2010
Objective - To assess the relationship between schizophrenia and cardiovascular disease by evaluating metabolic risk associated with treatment for schizophrenia, prevalence of cardiovascular risk factors (CV-RF) and disease (CV-D), and health care utilization in people with schizophrenia...
-
Spring 2016
Schizophrenia (SCZ) is a psychiatric disorder that, despite a high prevalence (1% population worldwide) and burden of disease (1% global burden of disease), has a poorly understood etiology. While symptoms of SCZ typically manifest during adolescence and early adulthood, there is a substantial...
-
Perineuronal nets and their role in cognitive impairment in central nervous system diseases
DownloadFall 2023
Perineuronal nets (PNNs) are organized components of the extracellular matrix that surround mature neurons of the central nervous system (CNS). These structures have neuroprotective properties for host cells, provide structural and functional stability, and have been implicated in brain functions...
-
Phasic Electrodermal Activity in Schizophrenia: Skin Conductance Response in Unmedicated Schizophrenic Patients in Comparison to Normal Controls
DownloadSpring 2012
Stimulus-elicited (phasic) skin conductance responses (SCRs) to indifferent stimuli have often been employed to examine abnormalities in orienting (allocation of attention) in studies of schizophrenia. Most previous studies have examined phasic activity only during habituation paradigms....